U.S. Oncology Drugs Market Size, Share, Analysis, By Drugs Class (Cytotoxic Drugs {Alkylating Agents, Antimetabolites, and Others}, Targeted Drugs {Monoclonal Antibodies, and Others}, Hormonal Drugs, and Others), By Therapy (Chemotherapy, Targeted Therapy, and Immunotherapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, and Others), By Dosage Form (Solid {Tablets and Capsules}, Liquid, and Injectable), By Distribution Channel (Hospital Pharmacies, and Retail and Online Pharmacies), and Country Forecast, 2024-2032

Last Updated: December 15, 2025 | Format: PDF | Report ID: FBI108499

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Key Cancers, 2023
2. Pipeline Analysis, Key Players
3. Key Industry Developments: Mergers, Acquisitions, New Product Launches, Etc.
4. Regulatory & Reimbursement Scenario, By Key Countries
5. Impact of COVID-19 on the Market
U.S. Oncology Drugs Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Cytotoxic Drugs
    1. Alkylating Agents
    2. Antimetabolites
    3. Others
  2. Targeted Drugs
    1. Monoclonal Antibodies
    2. Others
  3. Hormonal Drugs
  4. Others
2. Market Analysis, Insights and Forecast – By Therapy
  1. Chemotherapy
  2. Targeted Therapy
  3. Immunotherapy
3. Market Analysis, Insights and Forecast – By Indication
  1. Lung Cancer
  2. Stomach Cancer
  3. Colorectal Cancer
  4. Breast Cancer
  5. Prostate Cancer
  6. Others
4. Market Analysis, Insights and Forecast – By Dosage Form
  1. Solid
    1. Tablets
    2. Capsules
  2. Liquid
  3. Injectable
    1. Prefilled Syringes
    2. Others
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail and Online Pharmacies
Competitive Analysis
1. U.S. Market Share Analysis (2023)
2. Company Profiles
  1. Genentech, Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  2. F. Hoffmann-La Roche Ltd.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  3. Novartis AG
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  4. Pfizer Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  5. Bristol Myers Squibb Company
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  6. GlaxoSmithKline plc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  7. Eli Lilly and Company
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developmnts
    5. Strategies
    6. financials (Based on Availability)
  8. AstraZeneca
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  9. Sanofi
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  10. Bayer AG
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  11. Merck & Co., Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Key Cancers, 2023
2. Pipeline Analysis, Key Players
3. Key Industry Developments: Mergers, Acquisitions, New Product Launches, Etc.
4. Regulatory & Reimbursement Scenario, By Key Countries
5. Impact of COVID-19 on the Market
U.S. Oncology Drugs Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug Class
  1. Cytotoxic Drugs
    1. Alkylating Agents
    2. Antimetabolites
    3. Others
  2. Targeted Drugs
    1. Monoclonal Antibodies
    2. Others
  3. Hormonal Drugs
  4. Others
2. Market Analysis, Insights and Forecast – By Therapy
  1. Chemotherapy
  2. Targeted Therapy
  3. Immunotherapy
3. Market Analysis, Insights and Forecast – By Indication
  1. Lung Cancer
  2. Stomach Cancer
  3. Colorectal Cancer
  4. Breast Cancer
  5. Prostate Cancer
  6. Others
4. Market Analysis, Insights and Forecast – By Dosage Form
  1. Solid
    1. Tablets
    2. Capsules
  2. Liquid
  3. Injectable
    1. Prefilled Syringes
    2. Others
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail and Online Pharmacies
Competitive Analysis
1. U.S. Market Share Analysis (2023)
2. Company Profiles
  1. Genentech, Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  2. F. Hoffmann-La Roche Ltd.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  3. Novartis AG
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  4. Pfizer Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  5. Bristol Myers Squibb Company
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  6. GlaxoSmithKline plc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  7. Eli Lilly and Company
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developmnts
    5. Strategies
    6. financials (Based on Availability)
  8. AstraZeneca
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  9. Sanofi
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  10. Bayer AG
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  11. Merck & Co., Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)

Read Less

List of Figures

Figure 1: U.S. Oncology Drugs Market Revenue Breakdown (USD billion, %) by Drug Class, 2024 & 2032

Figure 2: U.S. Oncology Drugs Market Value Share (%), by Drug Class, 2024 & 2032

Figure 3: U.S. Oncology Drugs Market Value Share (%), by Therapy, 2024 & 2032

Figure 4: U.S. Oncology Drugs Market Value Share (%), by Indication, 2024 & 2032

Figure 5: U.S. Oncology Drugs Market Value Share (%), by Dosage Form, 2024 & 2032

Figure 6: U.S. Oncology Drugs Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 7: U.S. Oncology Drugs Market Share (%), By Company, 2023

List of Tables

Table 1: U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 2: U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019-2032

Table 3: U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019-2032

Table 4: U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Therapy, 2019-2032

Table 5: U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 6: U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Dosage Form, 2019-2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2023
HISTORICAL DATA: 2019-2022
NO OF PAGES: 90

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com